These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 8036586)

  • 21. Juvenile Behçet's disease in Israel. The Pediatric Rheumatology Study Group of Israel.
    Uziel Y; Brik R; Padeh S; Barash J; Mukamel M; Harel L; Press J; Tauber T; Rakover Y; Wolach B
    Clin Exp Rheumatol; 1998; 16(4):502-5. PubMed ID: 9706437
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The HLA pattern in Adamantiades-Behçet's disease in Germany. Association of occurrence, clinical symptoms and follow-up in 39 patients].
    Zouboulis CC; Büttner P; Djawari D; Kirch W; Keitel W; Garbe C; von Keyserlingk-Eberius HJ; Orfanos CE
    Hautarzt; 1993 Feb; 44(2):81-5. PubMed ID: 8449698
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Behçet's disease: lack of correlation of clinical manifestations with HLA antigens.
    Müftüoğlu AU; Yazici H; Yurdakul S; Pazarli H; Ozyazgan Y; Tüzün Y; Altaç M; Yalçin B
    Tissue Antigens; 1981 Feb; 17(2):226-30. PubMed ID: 7233417
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Behçet's disease associated with one of the HLA-B51 subantigens, HLA-B* 5101.
    Mizuki N; Inoko H; Ando H; Nakamura S; Kashiwase K; Akaza T; Fujino Y; Masuda K; Takiguchi M; Ohno S
    Am J Ophthalmol; 1993 Oct; 116(4):406-9. PubMed ID: 8213969
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic association of HLA-A*2601 with ocular Behçet's disease in Japanese patients.
    Kaburaki T; Takamoto M; Numaga J; Kawashima H; Araie M; Ohnogi Y; Harihara S; Kuwata S; Takeuchi F
    Clin Exp Rheumatol; 2010; 28(4 Suppl 60):S39-44. PubMed ID: 20868569
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Familial Behçet's disease.
    Akpolat T; Koç Y; Yeniay I; Akpek G; Güllü I; Kansu E; Kiraz S; Ersoy F; Batman F; Kansu T
    Eur J Med; 1992 Nov; 1(7):391-5. PubMed ID: 1341477
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of HLA-B51 subtypes and Behçet's disease in Spain.
    González-Escribano MF; Rodríguez MR; Walter K; Sanchez-Roman J; García-Lozano JR; Núñez-Roldán A
    Tissue Antigens; 1998 Jul; 52(1):78-80. PubMed ID: 9714478
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HLA antigen, severity and acetylator phenotype in Behçet's disease patients with non-relative parents.
    Sharquie KE; Najim RA; Al-Janabi MH
    Adv Exp Med Biol; 2003; 528():139-42. PubMed ID: 12918678
    [No Abstract]   [Full Text] [Related]  

  • 29. MICA transmembrane region polymorphism and HLA B51 in Tunisian Behçet's disease patients.
    Ben Ahmed M; Houman H; Abdelhak S; Ben Ghorbel I; Miled M; Dellagi K; Louzir H
    Adv Exp Med Biol; 2003; 528():225-8. PubMed ID: 12918695
    [No Abstract]   [Full Text] [Related]  

  • 30. Association of Behçet's syndrome with HLA-B5 in the Mexican mestizo population.
    Lavalle C; Alarcon-Segovia D; Del Giudice-Knipping JA; Fraga A
    J Rheumatol; 1981; 8(2):325-7. PubMed ID: 7230164
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of MICA polymorphism with HLA-B51 and disease severity in Korean patients with Behcet's disease.
    Park SH; Park KS; Seo YI; Min DJ; Kim WU; Kim TG; Cho CS; Mok JW; Park KS; Kim HY
    J Korean Med Sci; 2002 Jun; 17(3):366-70. PubMed ID: 12068141
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HLA class I genotyping including HLA-B*51 allele typing in the Iranian patients with Behçet's disease.
    Mizuki N; Ota M; Katsuyama Y; Yabuki K; Ando H; Yoshida M; Onari K; Nikbin B; Davatchi F; Chams H; Ghaderi AA; Ohno S; Inoko H
    Tissue Antigens; 2001 May; 57(5):457-62. PubMed ID: 11556970
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An immunogenetic basis for the tissue involvement in Behçet's syndrome.
    Lehner T; Batchelor JR; Challacombe SJ; Kennedy L
    Immunology; 1979 Aug; 37(4):895-900. PubMed ID: 500134
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Primary association of HLA-B51 with Behçet's disease in Ireland.
    Kilmartin DJ; Finch A; Acheson RW
    Br J Ophthalmol; 1997 Aug; 81(8):649-53. PubMed ID: 9349151
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Familial cases of Behcet's disease.
    Dündar SV; Gençalp U; Simşek H
    Br J Dermatol; 1985 Sep; 113(3):319-21. PubMed ID: 4063168
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HLA typing for class I and class H antigens in Iraqi patients with Behçet's disease (sporadic and familial cases).
    Al-Joofy IKh; Muslih RK; Mousawy KM; Al-Waiz MM
    Adv Exp Med Biol; 2003; 528():217-20. PubMed ID: 12918693
    [No Abstract]   [Full Text] [Related]  

  • 37. [Immunogenetic mechanism of Behçet's disease].
    Mizuki N; Ohno S; Kamata K; Nakamura S; Ishihara M; Sato K; Inaba G; Tsuji K; Inoko H
    Nippon Ganka Gakkai Zasshi; 1991 Aug; 95(8):783-9. PubMed ID: 1950836
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of Major Histocompatibility Complex Class I Chain-Related Gene A and HLA-B Alleles with Behçet's Disease in Turkey.
    Mizuki N; Meguro A; Tohnai I; Gül A; Ohno S; Mizuki N
    Jpn J Ophthalmol; 2007; 51(6):431-6. PubMed ID: 18158593
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Failure to find a B51 IEF variant associated with Behçet's disease.
    Baricordi OR; Melchiorri L; Balboni A; Perrone S; Pivetti-Pezzi P; Sensi A
    Dis Markers; 1988; 6(4):275-7. PubMed ID: 3233883
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gender-specific differences in Adamantiades-Behçet's disease manifestations: an analysis of the German registry and meta-analysis of data from the literature.
    Bonitsis NG; Luong Nguyen LB; LaValley MP; Papoutsis N; Altenburg A; Kötter I; Micheli C; Maldini C; Mahr A; Zouboulis CC
    Rheumatology (Oxford); 2015 Jan; 54(1):121-33. PubMed ID: 25118314
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.